<DOC>
	<DOCNO>NCT03034850</DOCNO>
	<brief_summary>Cytoreductive surgery ( CRS ) hyperthermic intraperitoneal peroperative chemotherapy ( HIPEC ) , indicate patient peritoneal metastasis digestive gynecological malignancy alike , demonstrate considerable impact hemostatic metabolism , platelet coagulation level . The potential hemostatic interference CRS HIPEC phase dependent . This study demonstrate combine use ROTEM ( rotational thromboelastometry ) , PACT ( platelet activation test ) CAT ( thrombin generation test ) assay CRS HIPEC follow-up 7 day postoperative .</brief_summary>
	<brief_title>Thrombin Generation Platelet Activation CRS/HIPEC</brief_title>
	<detailed_description>The purpose study quantitatively assess impact CRS HIPEC , various component hemostasis . Routine laboratory assay activate clotting time , activate partial thromboplastin time , prothrombin time , platelet count might , demonstrate previously , insufficiently provide specificity and/or sensitivity ass coagulation platelet disorder . Therefore , additionally thrombin generation ( TG ) analyze calibrate automated thrombogram assay ( CAT ) . Also , platelet function quantitatively assess PAC-t-UB assay rotational thromboelastometry ( ROTEM ) use elucidate contribution platelet , intrinsic extrinsic coagulation pathways peri-operative bleeding . The hypothesis study procedure expose increase thrombotic risk , result faster increase TG hyper platelet function ?</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Pseudomyxoma Peritonei</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>confirm histological diagnosis peritoneal disease ( e.g. , mesothelioma ; pseudomyxoma peritonei ; colorectal , ovarian , gastric peritoneal carcinomatosis colorectal , ovarian , gastric cancer origin ; abdominal sarcomatosis ) ; age &lt; 80 year ; cardiac , renal , hepatic , bone marrow function compatible surgery ; inform write consent participate study ( ) inherit coagulation abnormality , active systemic infection , interstitial lung disease , serious cardiac dysrhythmia condition , New York Heart Association classification III IV , congestive cardiac failure , uncontrolled hypertension ( diastolic blood pressure constantly &gt; 100 mm Hg , systolic blood pressure constantly &gt; 180 mm Hg ) . inadequate bone marrow function begin trial , define platelet count less &lt; 150 GPT/L neutrophil granulocyte count less &lt; 1.5 GPT/L . inadequate renal function begin trial , define GFR less &lt; 60 ml/min , inadequate liver function begin trial , define bilirubin &gt; 1.5 time ULN ( upper limit normal ) , active hepatitis B C infection , female patient pregnant breast feed participation another therapeutic clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>cytoreductive surgery</keyword>
	<keyword>hyperthermic intraperitoneal peroperative chemotherapy</keyword>
	<keyword>platelet function</keyword>
	<keyword>thrombin generation</keyword>
	<keyword>thromboelastometry</keyword>
</DOC>